Correlation Between Shuttle Pharmaceuticals and ISpecimen

Can any of the company-specific risk be diversified away by investing in both Shuttle Pharmaceuticals and ISpecimen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shuttle Pharmaceuticals and ISpecimen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Shuttle Pharmaceuticals and iSpecimen, you can compare the effects of market volatilities on Shuttle Pharmaceuticals and ISpecimen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shuttle Pharmaceuticals with a short position of ISpecimen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shuttle Pharmaceuticals and ISpecimen.

Diversification Opportunities for Shuttle Pharmaceuticals and ISpecimen

0.18

Correlation Coefficient

Shuttle Pharmaceuticals  ISpecimen

Average diversification

The 3 months correlation between Shuttle and ISpecimen is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Shuttle Pharmaceuticals and iSpecimen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iSpecimen and Shuttle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shuttle Pharmaceuticals are associated (or correlated) with ISpecimen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iSpecimen has no effect on the direction of Shuttle Pharmaceuticals i.e., Shuttle Pharmaceuticals and ISpecimen go up and down completely randomly.

Pair Corralation between Shuttle Pharmaceuticals and ISpecimen

Given the investment horizon of 90 days Shuttle Pharmaceuticals is expected to generate 50.77 times less return on investment than ISpecimen. But when comparing it to its historical volatility, Shuttle Pharmaceuticals is 4.51 times less risky than ISpecimen. It trades about 0.0 of its potential returns per unit of risk. iSpecimen is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  103.00  in iSpecimen on July 21, 2025 and sell it today you would lose (29.00) from holding iSpecimen or give up 28.16% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Shuttle Pharmaceuticals  vs.  iSpecimen

Shuttle Pharmaceuticals

Risk-Adjusted Performance

Weakest

Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Shuttle Pharmaceuticals is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

iSpecimen

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in iSpecimen are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, ISpecimen exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Shuttle Pharmaceuticals and ISpecimen

The main advantage of trading using opposite Shuttle Pharmaceuticals and ISpecimen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shuttle Pharmaceuticals position performs unexpectedly, ISpecimen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ISpecimen will offset losses from the drop in ISpecimen's long position.

The idea behind Shuttle Pharmaceuticals and iSpecimen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.